Market Closed -
Nasdaq Stockholm
12:00:00 2024-06-10 pm EDT
|
5-day change
|
1st Jan Change
|
0.264
SEK
|
-0.75%
|
|
+5.60%
|
-12.87%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
68.2
|
87.51
|
55.39
|
9.611
|
Enterprise Value (EV)
1 |
58.37
|
50.9
|
43.39
|
-3.618
|
P/E ratio
|
-4.41
x
|
-7.24
x
|
-2.26
x
|
-0.33
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
-3,223,709
x
|
-10,003,651
x
|
-2,762,446
x
|
240,832
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
4.39
x
|
2.2
x
|
3.62
x
|
0.58
x
|
Nbr of stocks (in thousands)
|
6,916
|
13,847
|
13,847
|
31,721
|
Reference price
2 |
9.860
|
6.320
|
4.000
|
0.3030
|
Announcement Date
|
5/3/21
|
5/2/22
|
5/9/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
0.5379
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-6.117
|
-6.872
|
-14.98
|
-12.14
|
-24.95
|
-24
|
Operating Margin
|
-
|
-1,277.53%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-6.134
|
-7.408
|
-15.49
|
-12.09
|
-24.53
|
-23.74
|
Net income
1 |
-6.134
|
-7.408
|
-15.49
|
-12.09
|
-24.53
|
-23.74
|
Net margin
|
-
|
-1,377.25%
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-1.822
|
-2.237
|
-0.8731
|
-1.771
|
-0.9214
|
Free Cash Flow
|
-
|
3.068
|
-18.11
|
-5.088
|
-15.71
|
-15.02
|
FCF margin
|
-
|
570.45%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/18/19
|
4/21/20
|
5/3/21
|
5/2/22
|
5/9/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2.18
|
2.47
|
9.82
|
36.6
|
12
|
13.2
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
3.07
|
-18.1
|
-5.09
|
-15.7
|
-15
|
ROE (net income / shareholders' equity)
|
-79.9%
|
-217%
|
-203%
|
-43.7%
|
-89%
|
-149%
|
ROA (Net income/ Total Assets)
|
-41.4%
|
-45.9%
|
-67.6%
|
-24.6%
|
-49.7%
|
-73.4%
|
Assets
1 |
14.81
|
16.15
|
22.92
|
49.11
|
49.37
|
32.32
|
Book Value Per Share
|
-
|
-0.0700
|
2.250
|
2.870
|
1.100
|
0.5200
|
Cash Flow per Share
|
-
|
0.9400
|
1.570
|
2.710
|
0.9300
|
0.4400
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/18/19
|
4/21/20
|
5/3/21
|
5/2/22
|
5/9/23
|
4/17/24
|
|
1st Jan change
|
Capi.
|
---|
| -12.87% | 797K | | +18.77% | 125B | | +14.05% | 108B | | -7.16% | 23.64B | | +2.07% | 22.39B | | -10.79% | 17.78B | | -41.74% | 16.43B | | -13.47% | 16.34B | | +2.23% | 13.56B | | +27.13% | 11.59B |
Bio Therapeutic Drugs
|